Details for New Drug Application (NDA): 207236
✉ Email this page to a colleague
The generic ingredient in MEMANTINE HYDROCHLORIDE is donepezil hydrochloride; memantine hydrochloride. There are thirty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride; memantine hydrochloride profile page.
Summary for 207236
Tradename: | MEMANTINE HYDROCHLORIDE |
Applicant: | Lannett Co Inc |
Ingredient: | memantine hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 207236
Mechanism of Action | NMDA Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 207236
Suppliers and Packaging for NDA: 207236
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 207236 | ANDA | Lannett Company, Inc. | 0527-1221 | 0527-1221-05 | 500 TABLET in 1 BOTTLE, PLASTIC (0527-1221-05) |
MEMANTINE HYDROCHLORIDE | memantine hydrochloride | TABLET;ORAL | 207236 | ANDA | Lannett Company, Inc. | 0527-1221 | 0527-1221-06 | 60 TABLET in 1 BOTTLE, PLASTIC (0527-1221-06) |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
Approval Date: | Nov 10, 2016 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Nov 10, 2016 | TE: | RLD: | No |
Complete Access Available with Subscription